Blood test may replace scans and biopsies for rare bone tumor
NCT ID NCT07609277
First seen May 27, 2026 · Last updated Jun 17, 2026 · Updated 4 times
Summary
This study looks at whether a blood test for a substance called TRACP-5b can help doctors diagnose and monitor giant cell tumor of bone (GCTB), a rare but aggressive bone tumor. Currently, patients need regular CT or MRI scans and sometimes invasive biopsies to check if the tumor has returned. Researchers will measure TRACP-5b levels in blood samples from 70 adults with GCTB during routine visits and compare them to imaging and biopsy results. If successful, this could lead to a simpler, less invasive way to detect recurrences earlier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL TUMOR OF BONE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Department of Orthopaedic Surgery, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czechia
RECRUITINGBrno, 60200, Czechia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.